Advair.com | Site map | Glossary | Important information about ADVAIR DISKUS® 250/50   
 
COPD
 Home
 What Is COPD?
 How to Manage COPD
 How ADVAIR Helps
 Living With
 Family Members
    MORE AIR BY ADVAIR
    If you have COPD associated with chronic bronchitis, the Breathe
    Easier Program may help.
  Sign up today and you may be eligible to receive:
   Information in the mail to help you manage your COPD
   A coupon for a free 30-day trial of ADVAIR 250/50 (if you're
     new to ADVAIR)
   A check for $ 10 toward your next prescription (if you currently
     use ADVAIR)
 Breathe Easier sign-up form
            * Indicates required field
        * First Name: 
              * Last Name: 
                  * Address: 
                                   
                        * City: 
                      * State: 
                * ZIP Code:   
           * Date of Birth:     
           E-mail address: 
                                   (e.g. name@domain.com)
    Has a doctor or other healthcare professional ever told you
          that you have COPD, chronic bronchitis, or emphysema?
            Yes
            No
    Have you ever filled a prescription for ADVAIR DISKUS?
            No
            Yes, I've been on ADVAIR for less than 6 months
            Yes, I've been on ADVAIR for more than 6 months
    Please check any of the following medicines you have
          used before for your COPD.
§
            Spiriva®
            Atrovent®
            Combivent®
            Other®
    If you smoke, do you want information about how to
          quit?
            Yes
            No


           By providing your name, address, e-mail address, and other            information, you are giving GlaxoSmithKline (GSK) and            companies working with GSK permission to market or
           advertise to you regarding the medical condition(s) in which            you've expressed an interest, as well as other general health
           related information from GSK. GlaxoSmithKline will not sell
           or transfer your name, address, or e-mail address to any
           other party for their own marketing use.

           For additional information on how GSK handles your information,            please read our privacy statement.
              

 Measured by a breathing test in people taking ADVAIR 250/50,
   compared with people taking fluticasone 250 mcg or salmeterol
   50 mcg.


 Fulfillment subject to eligibility. Offers good while supplies last.
   Click here for complete eligibility rules.


§ These brands are trademark of their respective owners and
   are not trademarks of The GlaxoSmithKline Group of Comapnies.    The makers of these brands are not affiliated with and do not    endorse GlaxoSmithKline or its products.

             

  If you do not want to receive future communications about breathing   conditions and treatment options, please call 1-888-825-5249 from
  8 am to 8 pm Monday through Friday.




Important information about ADVAIR DISKUS 250/50
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems. ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.

Complete Prescribing Information and Medication Guide for ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder).

This site is intended for US residents only.
© 1997-2008 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us